[1]
2013. Development of CL184 human monoclonal antibody combination for rabies post-exposure prophylaxis, from preclinical design to clinical evaluation. Revista de Educação Continuada em Medicina Veterinária e Zootecnia do CRMV-SP. 10, 2/3 (ago. 2013), 45–45.